Interstitial Lung Disease

Common Name(s)

Interstitial Lung Disease

Interstitial lung disease describes a group of disorders caused by damage to the lungs, which are the organs through which we breathe. This damage can cause difficulty breathing and low oxygen levels in the blood. Although the exact cause of interstitial lung disease is unknown, it can be triggered by various injuries resulting in scarring within the lungs. Normally, the body fixes the damaged lung tissue, but in patients with interstitial lung disease the repair process does not function properly, causing thick and scarred air sacs. Other risk factors include long-term exposure to hazardous materials, certain autoimmune diseases, such as rheumatoid arthritis, age, and smoking. Once the lung tissue starts scarring, medication can only slow down the damage but it cannot reverse the damage. Treatment may include radiation, chemotherapy drugs, heart medications or antibiotics.

Source: Advocacy organizations associated with the condition.

 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Interstitial Lung Disease" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Interstitial Lung Disease" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Interstitial Lung Disease" returned 519 free, full-text research articles on human participants. First 3 results:

Prognostic factors and outcomes in Japanese lung transplant candidates with interstitial lung disease.
 

Author(s): Kohei Ikezoe, Tomohiro Handa, Kiminobu Tanizawa, Toyofumi F Chen-Yoshikawa, Takeshi Kubo, Akihiro Aoyama, Hideki Motoyama, Kyoko Hijiya, Shinsaku Tokuda, Yoshinari Nakatsuka, Yuko Yamamoto, Ayako Oshima, Shin-Ichi Harashima, Sonoko Nagai, Toyohiro Hirai, Hiroshi Date, Kazuo Chin

Journal:

 

Young patients with advanced interstitial lung disease (ILD) are potential candidates for cadaveric lung transplantation. This study aimed to examine clinical features, outcomes, and prognostic factors in Japanese ILD patients awaiting lung transplantation.

Last Updated: 11 Aug 2017

Go To URL
Thoracoabdominal asynchrony: Two methods in healthy, COPD, and interstitial lung disease patients.
 

Author(s): Mayra Caleffi Pereira, Desiderio Cano Porras, Adriana Claudia Lunardi, Cibele Cristine Berto Marques da Silva, Renata Cléia Claudino Barbosa, Letícia Zumpano Cardenas, Renata Pletsch, Jeferson George Ferreira, Isac de Castro, Celso Ricardo Fernandes de Carvalho, Pedro Caruso, Carlos Roberto Ribeiro de Carvalho, André Luis Pereira de Albuquerque

Journal:

 

Thoracoabdominal asynchrony is the nonparallel motion of the ribcage and abdomen. It is estimated by using respiratory inductive plethysmography and, recently, using optoelectronic plethysmography; however the agreement of measurements between these 2 techniques is unknown. Therefore, ...

Last Updated: 2 Aug 2017

Go To URL
Predictors of lung function test severity and outcome in systemic sclerosis-associated interstitial lung disease.
 

Author(s): Noémie Le Gouellec, Alain Duhamel, Thierry Perez, Anne-Lise Hachulla, Vincent Sobanski, Jean-Baptiste Faivre, Sandrine Morell-Dubois, Marc Lambert, Pierre-Yves Hatron, Eric Hachulla, Hélène Béhal, Regis Matran, David Launay, Martine Remy-Jardin

Journal:

 

Systemic sclerosis-related interstitial lung disease (SSc-ILD) is the leading cause of death in SSc. In this study, we aimed to describe the baseline severity and evolution of forced vital capacity (FVC) and diffusing capacity for carbon monoxide (DLCO) in patients with SSc-ILD and ...

Last Updated: 1 Aug 2017

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Interstitial Lung Disease" returned 91 free, full-text review articles on human participants. First 3 results:

Oxygen therapy for interstitial lung disease: a systematic review.
 

Author(s): Emily C Bell, Narelle S Cox, Nicole Goh, Ian Glaspole, Glen P Westall, Alice Watson, Anne E Holland

Journal:

 

This review aims to establish the impact of oxygen therapy on dyspnoea, health-related quality of life (HRQoL), exercise capacity and mortality in interstitial lung disease (ILD).We included studies that compared oxygen therapy to no oxygen therapy in adults with ILD. No limitations ...

Last Updated: 22 Feb 2017

Go To URL
Pulmonary vascular and cardiac impairment in interstitial lung disease.
 

Author(s): Marios Panagiotou, Alistair C Church, Martin K Johnson, Andrew J Peacock

Journal:

 

Pulmonary vascular and cardiac impairment is increasingly appreciated as a major adverse factor in the natural history of interstitial lung disease. This clinically orientated review focuses on the current concepts in the pathogenesis, pathophysiology and implications of the detrimental ...

Last Updated: 18 Jan 2017

Go To URL
[Fatal acute interstitial lung disease associated with docetaxel administration: about a case and review of the literature].
 

Author(s): Sami Aziz Brahmi, Seddik Youssef, Fatima Zahra Ziani, Said Afqir

Journal:

 

Docetaxel is a chemotherapeutic agent belonging to the taxane family. This drug is widely used to treat cancers. Interstitial lung disease is a rare but serious toxicity due to the high mortality risk. We report a case of a patient with breast cancer who had fatal acute interstitial ...

Last Updated: 19 Sep 2016

Go To URL
 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Interstitial Lung Disease Registry Construction
 

Status: Recruiting

Condition Summary: Interstitial Lung Disease

 

Last Updated: 1 Aug 2017

Go to URL

Last Updated: 25 Oct 2016

Go to URL
Neuromuscular Electrical Stimulation in Patients With Interstitial Lung Disease
 

Status: Recruiting

Condition Summary: Interstitial Lung Disease

 

Last Updated: 3 Jul 2017

Go to URL